Palopegteriparatide is a mPEG conjugated parathyroid hormone 1-34.
Palopegteriparatide is a mPEG conjugated parathyroid hormone 1-34.
No indication information available.
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2022/12/16 | N/A | AVAILABLE |
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Product Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|---|---|---|---|---|---|---|---|
EMEA/H/C/005934 | Denmark | Orphan | Authorised | 2023/11/17 | 2023/09/14 | 4 |
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval Number |
---|
No HSA products found for this drug
Product Name | Approval Number | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Registration Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Registration Date | Ingredient |
---|---|---|---|---|---|
443870 | Active | 2025/02/19 | palopegteriparatide | ||
443872 | Active | 2025/02/19 | palopegteriparatide | ||
443871 | Active | 2025/02/19 | palopegteriparatide |